http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2013013455-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0c3a1dbc0cbfc650d855ff0e68d8fb
publicationDate 2014-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2013013455-A
titleOfInvention USE OF ANTI-CD19 ANTIBODY IMMUNOCATED WITH MAITANSINOID FOR THE TREATMENT OF SYMPTOM OF CELL TUMORS B.
abstract An anti-CD19 maitansinoid immunoconjugate is used to treat the symptom of CD19 B cell tumors, in particular non-Hodgkin lymphoma.
priorityDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475332
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3100
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129538
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID930
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415827489
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506968
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848

Total number of triples: 50.